Aridis Pharmaceuticals Inc. Banner Image

Aridis Pharmaceuticals Inc.

  • Ticker ARDS
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Aridis Pharmaceuticals Inc. Logo Image
  • 11-50 Employees
  • Based in Los Gatos, California
Aridis Pharmaceuticals, Inc. discovers and develops anti-infectives to be used as add-on treatments to standard-of-care antibiotics. The Company is utilizing its proprietary ʎPEX™ and MabIgX® technology platforms to rapidly identify rare, potent antibody-producing B-cells from patients who have successfully overcome an infection, and to rapidly manufacture monoclonal antibody (mAbs) forMore therapeutic treatment of critical infections. These mAbs are already of human origin and functionally optimized for high potency by the donor's immune system; hence, they do not require genetic engineering or further optimization to achieve full functionality.
4.8 / 5.0 (270)

Aridis Pharmaceuticals Inc. reports have an aggregate usefulness score of 4.8 based on 270 reviews.

Aridis Pharmaceuticals Inc.

Most Recent Annual Report

Aridis Pharmaceuticals Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Aridis Pharmaceuticals Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!